Background Metabolic associated fatty liver disease (MAFLD) is a novel terminology
introduced in 2020 to provide a more accurate description of fatty liver disease associated …

Non‐alcoholic fatty liver disease (NAFLD) comprises a wide spectrum of pathologies
ranging from non‐alcoholic fatty liver (NAFL), characterized by simple steatosis without …

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease that
affects approximately one-quarter of the global adult population, posing a significant threat …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in Western countries that is predicted to become also the most frequent indication for liver …

This guidance provides a data‐supported approach to the diagnostic, therapeutic, and
preventive aspects of nonalcoholic fatty liver disease (NAFLD) care. A “Guidance” document …

Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver
disease in the United States and worldwide. The progressive form of NAFLD, nonalcoholic …

Nonalcoholic fatty liver disease may be the most common liver disease in the United States,
with a high prevalence in the obese, type 2 diabetic population, and it is probably …

NAFLD (non-alcoholic fatty liver disease) refers to a wide spectrum of liver damage, ranging
from simple steatosis to NASH (non-alcoholic steatohepatitis), advanced fibrosis and …

Non-alcoholic fatty liver disease (NAFLD) is a definition of a prevalent condition that has
been given a name describing what the disease is not, mainly due to gaps in the …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in
Western industrialised countries. The prevalence of NAFLD is increasing in parallel with the …